Andrew Sandler

Andrew Sandler currently serves as Chief Medical Officer at Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company focused on innovative immunotherapies. Previously, Andrew held the position of Chief Medical Officer at Kiadis Pharma and served as Senior Vice President of Medical Affairs at Medivation. Andrew's extensive career includes a significant tenure at Dendreon Pharmaceuticals, where several promotions culminated in the role of CMO and Executive Vice President of Research & Development, overseeing the commercialization of Provenge®. Prior roles as CMO at Spectrum Pharmaceuticals and leadership positions at Bayer HealthCare and Seattle Genetics further highlight Andrew's expertise in medical affairs and clinical development. Andrew's academic foundation includes a Doctor of Medicine from Icahn School of Medicine at Mount Sinai and specialized training in Hematology/Oncology at UCSF.